Immutep
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
IMMP Key Statistics
Stock Snapshot
The current Immutep(IMMP) stock price is $1.73, with a market capitalization of 253.17M. The stock trades at a price-to-earnings (P/E) ratio of -6.48.
As of 2025-11-05, Immutep(IMMP) stock has fluctuated between $1.70 and $1.79. The current price stands at $1.73, placing the stock +1.8% above today's low and -3.4% off the high.
The Immutep(IMMP)'s current trading volume is 71.74K, compared to an average daily volume of 133.55K.
In the last year, Immutep(IMMP) shares hit a 52-week high of $2.71 and a 52-week low of $1.32.
In the last year, Immutep(IMMP) shares hit a 52-week high of $2.71 and a 52-week low of $1.32.
IMMP News
Immutep (IMMP) announces it has received a EUR 2,588,954 research and development tax incentive payment in cash from the French Government under its Credit d’Im...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...